Campbell to Release Third-Quarter Fiscal 2020 Results on June 3, 2020
Campbell Soup Company (NYSE:CPB) today announced that it will release its third-quarter fiscal 2020 results on June 3, 2020, at approximately 7:00 a.m. ET.
In addition to a press release, Campbell will post a pre-recorded management presentation and remarks. Given the unprecedented circumstances related to the COVID-19 pandemic, Campbell is taking this approach to allow more time for a live question and answer session for analysts. The materials will be available at investor.campbellsoupcompany.com/events-and-presentations.
Press release issued at approximately 7:00 a.m. ET
Pre-recorded management presentation and remarks posted at approximately 7:15 a.m. ET
Live question and answer session for analysts with Mark Clouse, Chief Executive Officer, and Mick Beekhuizen, Chief Financial Officer, at 8:30 a.m. ET
For those unable to participate in the Q&A session, a replay will be available at the above website approximately two hours after the conclusion of the call. The replay will also be available from approx. 11:30 a.m. ET on June 3, 2020, through 11:59 p.m. ET, June 17, 2020, by dialing +1 (404) 537-3406, access code: 3437559.
Campbell intends to use its investor relations website to make future announcements of material financial and other information. Investors and other interested persons are encouraged to regularly check the website for such information. Campbell also will, from time to time, disclose this information through press releases, filings furnished or filed with the Securities and Exchange Commission, conference calls and/or webcasts.
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...